Advertisement

Topics

Nexia Biotechnologies Inc Company Profile

10:37 EDT 22nd June 2018 | BioPortfolio

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.

Location

P.O. BOX 187Branch Jean-Talon
Montreal
Quebec
H1S 2Z2
Canada

Contact

Phone: 514.586.3942
Fax: 514.371.7880
Email: investors@nexiabiotech.com


News Articles [95 Associated News Articles listed on BioPortfolio]

CES 2018: Nexia Introduces Innovative New Features, Products to Further Enhance Consumers' ...

RoomIQ by Nexia, a feature for Trane and American Standard Heating, Ventilation, and Air Conditioning (HVAC) comfort systems, will use the system's Nexia-enabled thermostat Read more...

Deals this week: Refuge Biotechnologies, Attenua, Crescendo Biologics

US-based Refuge Biotechnologies Inc has raised $25m in a series B funding round led by 3SBio and Sequoia China. The...Read More... The post Deals this week: Refuge Biotechnologies, Attenua, Crescendo ...

#jobs #lifescience FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Development) x 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Developmen...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Aegea Biotechnologies' next generation nucleic acid clinical diagnostic technologies gets US, Australian & Chinese patents

Aegea Biotechnologies, a biotechnology company, announces the issuance of a collection of patents including US Patent 9,428,747 entitled methods for amplification of nucleic acids utilising hairpin lo...

Arbor Biotechnologies Comes Out of Stealth Mode

Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.

Azelis and Tagra Biotechnologies Extend Partnership

Israel’s Tagra Biotechnologies has appointed Azelis as the exclusive distributor of its range of Release on Demand (RND) microcapsules for all personal care applications in France and Benelux, w...

CEO Salzman, CMO Contouriotis Resign from Adverum Biotechnologies

Amber Salzman has resigned from her position as president and CEO of Adverum Biotechnologies (NASDAQ: ADVM) effective May 3. She has also stepped down from the Menlo Park, CA, gene therapy developer...

Drugs and Medications [0 Results]

None

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Dental, Oral, and Craniofacial Regenerative Medicine: Transforming Biotechnologies for Innovating Patient Care.

Rebooting Bioresilience: A Multi-OMICS Approach to Tackle Global Catastrophic Biological Risks and Next-Generation Biothreats.

Global Catastrophic Biological Risks (GCBRs) refer to biological events-natural, deliberate, and accidental-of a global and lasting impact. This challenges the life scientists to raise their game on t...

Recent Advances in Liquid Metal Manipulation toward Soft Robotics and Biotechnologies.

Interest has grown significantly in the field of soft robotics, which seeks to develop machinery capable of duplicating the elastic and rheological properties of typically polymeric or elastomeric bio...

Technologies for the bioconversion of methane into more valuable products.

Methane, with a global warming potential twenty five times higher than that of CO2 is the second most important greenhouse gas emitted nowadays. Its bioconversion into microbial molecules with a high ...

Clinical Trials [0 Results]

None

Companies [105 Associated Companies listed on BioPortfolio]

Nexia Biotechnologies Incorporated

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...

Nexia Biotechnologies Inc

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Nexia Holdings, Inc.

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Nexia Biotechnologies Inc" on BioPortfolio

We have published hundreds of Nexia Biotechnologies Inc news stories on BioPortfolio along with dozens of Nexia Biotechnologies Inc Clinical Trials and PubMed Articles about Nexia Biotechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Inc Companies in our database. You can also find out about relevant Nexia Biotechnologies Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record